vs
Side-by-side financial comparison of Krispy Kreme, Inc. (DNUT) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
Krispy Kreme, Inc. is the larger business by last-quarter revenue ($392.4M vs $207.8M, roughly 1.9× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -7.1%, a 64.5% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $27.9M).
Krispy Kreme, Inc. is an American multinational doughnut company and coffeehouse chain. Krispy Kreme was founded by Vernon Rudolph (1915–1973), who bought a yeast-raised recipe from a New Orleans chef, rented a building in 1937 in what is now historic Old Salem in Winston-Salem, North Carolina, and began selling to local grocery stores. Steady growth preceded an ambitious expansion as a public company in the period 2000 to 2016, which ultimately proved unprofitable. In 2016, the company retur...
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
DNUT vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $392.4M | $207.8M |
| Net Profit | $-27.8M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | -1.9% | 52.2% |
| Net Margin | -7.1% | 57.4% |
| Revenue YoY | -2.9% | — |
| Net Profit YoY | -23.8% | 330.1% |
| EPS (diluted) | $-0.18 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $392.4M | — | ||
| Q3 25 | $375.3M | $207.8M | ||
| Q2 25 | $379.8M | — | ||
| Q1 25 | $375.2M | — | ||
| Q4 24 | $404.0M | — | ||
| Q3 24 | $379.9M | $0 | ||
| Q2 24 | $438.8M | $0 | ||
| Q1 24 | $442.7M | $0 |
| Q4 25 | $-27.8M | — | ||
| Q3 25 | $-19.4M | $119.2M | ||
| Q2 25 | $-435.3M | — | ||
| Q1 25 | $-33.3M | — | ||
| Q4 24 | $-22.4M | — | ||
| Q3 24 | $39.6M | $-51.8M | ||
| Q2 24 | $-5.5M | $-52.8M | ||
| Q1 24 | $-8.5M | $-39.6M |
| Q4 25 | -1.9% | — | ||
| Q3 25 | -1.9% | 52.2% | ||
| Q2 25 | -114.4% | — | ||
| Q1 25 | -5.4% | — | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | -4.2% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 2.7% | — |
| Q4 25 | -7.1% | — | ||
| Q3 25 | -5.2% | 57.4% | ||
| Q2 25 | -114.6% | — | ||
| Q1 25 | -8.9% | — | ||
| Q4 24 | -5.6% | — | ||
| Q3 24 | 10.4% | — | ||
| Q2 24 | -1.3% | — | ||
| Q1 24 | -1.9% | — |
| Q4 25 | $-0.18 | — | ||
| Q3 25 | $-0.11 | $1.33 | ||
| Q2 25 | $-2.55 | — | ||
| Q1 25 | $-0.20 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $0.23 | $-0.60 | ||
| Q2 24 | $-0.03 | $-0.68 | ||
| Q1 24 | $-0.05 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $42.4M | $786.9M |
| Total DebtLower is stronger | $911.9M | — |
| Stockholders' EquityBook value | $650.1M | $1.1B |
| Total Assets | $2.6B | $1.2B |
| Debt / EquityLower = less leverage | 1.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $42.4M | — | ||
| Q3 25 | $30.7M | $786.9M | ||
| Q2 25 | $21.3M | — | ||
| Q1 25 | $18.7M | — | ||
| Q4 24 | $29.0M | — | ||
| Q3 24 | $25.4M | $920.0M | ||
| Q2 24 | $28.6M | $701.7M | ||
| Q1 24 | $33.1M | $698.8M |
| Q4 25 | $911.9M | — | ||
| Q3 25 | $906.2M | — | ||
| Q2 25 | $889.4M | — | ||
| Q1 25 | $935.0M | — | ||
| Q4 24 | $844.5M | — | ||
| Q3 24 | $804.6M | — | ||
| Q2 24 | $895.0M | — | ||
| Q1 24 | $881.8M | — |
| Q4 25 | $650.1M | — | ||
| Q3 25 | $670.3M | $1.1B | ||
| Q2 25 | $693.6M | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.1B | $931.7M | ||
| Q1 24 | $1.2B | $935.3M |
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $3.1B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.1B | $1.2B | ||
| Q2 24 | $3.2B | $973.7M | ||
| Q1 24 | $3.2B | $961.5M |
| Q4 25 | 1.40× | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | 1.28× | — | ||
| Q1 25 | 0.85× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.68× | — | ||
| Q2 24 | 0.79× | — | ||
| Q1 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.0M | $142.2M |
| Free Cash FlowOCF − Capex | $27.9M | $142.2M |
| FCF MarginFCF / Revenue | 7.1% | 68.4% |
| Capex IntensityCapex / Revenue | 4.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $-64.0M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.0M | — | ||
| Q3 25 | $42.3M | $142.2M | ||
| Q2 25 | $-32.5M | — | ||
| Q1 25 | $-20.8M | — | ||
| Q4 24 | $27.0M | — | ||
| Q3 24 | $3.3M | $-49.2M | ||
| Q2 24 | $33.2M | $-32.9M | ||
| Q1 24 | $-17.7M | $-43.8M |
| Q4 25 | $27.9M | — | ||
| Q3 25 | $15.5M | $142.2M | ||
| Q2 25 | $-60.8M | — | ||
| Q1 25 | $-46.7M | — | ||
| Q4 24 | $-6.9M | — | ||
| Q3 24 | $-22.9M | $-49.7M | ||
| Q2 24 | $1.6M | $-33.9M | ||
| Q1 24 | $-46.8M | $-45.1M |
| Q4 25 | 7.1% | — | ||
| Q3 25 | 4.1% | 68.4% | ||
| Q2 25 | -16.0% | — | ||
| Q1 25 | -12.5% | — | ||
| Q4 24 | -1.7% | — | ||
| Q3 24 | -6.0% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | -10.6% | — |
| Q4 25 | 4.4% | — | ||
| Q3 25 | 7.1% | 0.0% | ||
| Q2 25 | 7.4% | — | ||
| Q1 25 | 6.9% | — | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 6.9% | — | ||
| Q2 24 | 7.2% | — | ||
| Q1 24 | 6.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.08× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
